- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2008-002158-40. Displaying page 1 of 1.
|EudraCT Number: 2008-002158-40||Sponsor Protocol Number: A6181120||Start Date*: 2008-07-22|
|Sponsor Name:Pfizer S.A.|
|Full Title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF SUNITINIB PLUS PREDNISONE VERSUS PREDNISONE IN PATIENTS WITH PROGRESSIVE METASTATIC HORMONE-REFRACTORY PROSTATE CANCER AFTER FAILURE OF A D...|
|Medical condition: (mHRPC) after failure of a docetaxel-based chemotherapy regimen Cáncer de próstata resistente a las hormonas metastático (CPRHm) tras el fracaso de una pauta de quimioterapia basada en el docetaxel|
|Population Age: Adults, Elderly||Gender: Male|
|Trial protocol: ES (Prematurely Ended) GB (Prematurely Ended) SE (Completed) DE (Prematurely Ended) PT (Prematurely Ended) SK (Prematurely Ended) DK (Prematurely Ended) CZ (Prematurely Ended) FR (Ongoing) FI (Prematurely Ended) BE (Completed) IT (Prematurely Ended)|
|Trial results: View results|
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
|Number of Trials to download:|
• Outside EU/EEA: Date study was submitted in EudraCT
Query did not match any studies.